Amneal Pharmaceuticals Long Term Deferred Assets (Quarterly) Trends

Amneal Pharmaceuticals, Inc. (AMRX)

14.50 -0.10 (-0.68%) USD | NASDAQ | Feb 20, 16:00

14.53 +0.03 (+0.21%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for AMRX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Corcept Therapeutics, Inc.	Upgrade
Pfizer Inc.	Upgrade
Apellis Pharmaceuticals, Inc.	--
Nektar Therapeutics	--
Innoviva, Inc.	Upgrade